Entyvio 300 mg lyophilized powder for injection Images
Generic Name: vedolizumab
This medication has been identified as Entyvio 300 mg lyophilized powder for injection. It is supplied by Takeda Pharmaceutical Company Limited.
Entyvio is used in the treatment of Ulcerative Colitis; Crohn's Disease, Maintenance; Crohn's Disease and belongs to the drug class selective immunosuppressants. There is no proven risk in humans during pregnancy. Entyvio 300 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Entyvio
- Generic Name
- vedolizumab
- Strength
- 300 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceutical Company Limited
- National Drug Code (NDC)
- 64764-0300
More about Entyvio (vedolizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (158)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.